Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
Titel:
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
Auteur:
Wang, Michael L Lee, Hun Chuang, Hubert Wagner-Bartak, Nicolaus Hagemeister, Frederick Westin, Jason Fayad, Luis Samaniego, Felipe Turturro, Francesco Oki, Yasuhiro Chen, Wendy Badillo, Maria Nomie, Krystle Rosa, Maria DeLa Zhao, Donglu Lam, Laura Addison, Alicia Zhang, Hui Young, Ken H Li, Shaoying Santos, David Medeiros, L Jeffrey Champlin, Richard Romaguera, Jorge Zhang, Leo